Biopharmaceuticals are the proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligo-nucleotides) used for therapeutic or in vivo diagnostic purposes, and are produced by means other than direct extraction from a native (non-engineered) biological source. Biopharmaceutical drugs account for the 8% of the total pharmaceutical sale, and are the fastest growing part of the market.
One of the key factors contributing to this market growth is the increased adoption of advanced technologies. The Global Biopharmaceuticals market has also been witnessing the trend of an increase in Research and Development activities. Thus they may turn out to have the most profound influence on the future practice of molecular medicine.
This report meticulously analyses the Biopharmaceuticals market by their types such as Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, Granulocyte-Colony Stimulating Factor, Recombinant Human Insulin, Interferon, Human Growth Hormones and Other. The report also analyzes the market for biopharmaceutical by therapeutic areas including Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other. The regions covered in this report include North America (U.S., Canada, Mexico), Europe (U.K., France, Italy, The Netherlands, Spain), Asia-Pacific (China, Japan, Australia, New Zealand), and Rest of the World (Africa, Latin America, Middle East).
This report provides comprehensive analysis of more than 25 top players of Bio-pharmaceuticals industry with respect to their company overview, financials, portfolio, recent developments and strategies.
Source: Expert Interviews, Government Authorities, Related associations/Institutes, Related Research Publication, Government Publication, Company Press Release, Company Annual Reports, Company Website, Company Publication, SEC Filings, Meticulous Analysis.